John L. Hays
Ohio State University Hospital
ORCID: 0000-0003-3140-8677Also affiliated with The Ohio State University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 9 papers. Top paper: “Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment”.
Christina M. Annunziata, John L. Hays, Liang Cao, Peter L. Choyke, Minshu Yu +8 more
Jacob S. Yount, Jason J. David, Mindy Hoang, Colin W. Stets, Tanios Bekaii‐Saab +6 more
Sarah Crafton, Jason J. David, Colin W. Stets, Nicholas Grosenbacher, James Lin Chen +2 more
Alison M. Newton, Sara Conroy, Anita Adib, Neema C. Adley, Scott A. Strassels +7 more
Roberta M. Ray, Alison M. Newton, Sandi L. Navarro, Jeannette M. Schenk, Holli A. Loomans‐Kropp +5 more
Leah R. Jager, Alison M. Newton, Xilin Li, Holli A. Loomans‐Kropp, John L. Hays +3 more
Sarah G. Wilkins, Varun Bansal, David Su, Jorge L. Gomez‐Mayorga, Kiran K. Turaga +11 more
Wafa Khadraoui, John L. Hays, Larry J. Copeland, Roberto Vargas, David M. O’Malley +2 more
Rakhsha Khatri, Patrick L. Quinn, Joanne Kim, Mary Dillhoff, Aslam Ejaz +7 more